{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T05:22:40Z","timestamp":1740633760390,"version":"3.38.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Horse antithymocyte globulin (hATG) is an important therapeutic option for aplastic anemia (AA). However, hATG carries the risk of fatal anaphylaxis, and skin tests are performed to identify high-risk patients. We report on the successful desensitization of two AA patients with positive skin tests to hATG.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>Case 1: A 72-year-old man with a history of successful treatment with rabbit ATG was referred for pancytopenia. Neutrophil, reticulocyte, and platelet counts were 546 \/\u00b5L, 32,000 \/\u00b5L, and 19,000 \/\u00b5L, despite the oral administration of eltrombopag and cyclosporine. Bone marrow biopsy showed hypocellularity, and he was diagnosed with relapsed severe AA. Case 2: A 69-year-old man was referred for anemia and thrombocytopenia, and diagnosed with non-severe AA. Neutrophil, reticulocyte, and platelet counts were 2,044 \/\u00b5L, 23,000 \/\u00b5L, and 37,000 \/\u00b5L. Bone marrow biopsy revealed hypocellularity. Neither patient had a history of allergy, and the skin prick test (SPT) of hATG was negative, but the intradermal test (IDT) was positive. The result of the IDT in case 2 was reproducible. They received hATG desensitization under close monitoring of vital signs in our high-care unit. The protocol consisted of gradually increasing doses of hATG (four intradermal, two subcutaneous, and four intravenous (IV) push) and some premedications prior to administration of the full dose IV drip. They completed the course without developing any systemic allergic reactions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Despite the risk of anaphylaxis, hATG desensitization can be beneficial in AA patients with a positive skin test, especially when no alternative is available or hATG is preferred.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40780-025-00421-w","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T12:08:56Z","timestamp":1740571736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Successful desensitization to horse antithymocyte globulin for aplastic anemia: two case reports and literature review"],"prefix":"10.1186","volume":"11","author":[{"given":"Satoshi","family":"Yuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuaki","family":"Oura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Isezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanayuki","family":"Kitahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohkan","family":"Funakoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"421_CR1","doi-asserted-by":"crossref","unstructured":"Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M et al. Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline. Br J Haematol. 2024;204(3):784\u2013804. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38247114\/10.1111\/bjh.19236","DOI":"10.1111\/bjh.19236"},{"key":"421_CR2","doi-asserted-by":"crossref","unstructured":"Scheinberg P, Nunez O, Weinstein B, Biancotto A, Wu CO, Young NS. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Engl J Med. 2011;365(5):430-8. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21812672\/10.1056\/NEJMoa1103975","DOI":"10.1056\/NEJMoa1103975"},{"key":"421_CR3","doi-asserted-by":"crossref","unstructured":"Hayakawa J, Kanda J, Akahoshi Y, Harada N, Kameda K, Ugai T et al. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. Int J Hematol. 2017;105(5):578\u2013\u200986. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28078653\/","DOI":"10.1007\/s12185-017-2179-3"},{"key":"421_CR4","doi-asserted-by":"crossref","unstructured":"Shin SH, Yoon JH, Yahng SA, Lee SE, Cho BS, Eom KS et al. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol. 2013;92(6):817\u2013\u200924. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23318980\/10.1007\/s00277-013-1674-8","DOI":"10.1007\/s00277-013-1674-8"},{"key":"421_CR5","doi-asserted-by":"crossref","unstructured":"Vallejo C, Montesinos P, Polo M, Cuevas B, Morado M, Rosell A et al. Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis. Ann Hematol. 2015;94(6):947\u2013\u200954. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25672649\/10.1007\/s00277-015-2305-3","DOI":"10.1007\/s00277-015-2305-3"},{"key":"421_CR6","doi-asserted-by":"crossref","unstructured":"Suzuki T, Kobayashi H, Kawasaki Y, Okazuka K, Hatano K, Fujiwara S et al. Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations. Int J Hematol. 2016;104(4):446\u2013\u200953. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27338268\/10.1007\/s12185-016-2046-7","DOI":"10.1007\/s12185-016-2046-7"},{"key":"421_CR7","unstructured":"Pharmacia. & Upjohn Company LLC, a Pfizer company. ATGAM, product information, revised September 2023 [Internet]. 2024 [cited 2024 December 19]. Available from: http:\/\/www.fda.gov"},{"key":"421_CR8","unstructured":"Pfizer Pharmaceuticals Inc. ATGAM, package inserts, revised February 2024 [Internet]. 2024 [cited 2024 December 19]. Available from: https:\/\/www.pmda.go.jp"},{"key":"421_CR9","doi-asserted-by":"crossref","unstructured":"Wolanin SA, Demain JG, Meier EA. Successful desensitization of a patient with aplastic anemia to antithymocyte globulin. Allergy Rhinol (Providence). 2015;6(1):64\u2013\u20097. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25730287\/.","DOI":"10.2500\/ar.2015.6.0110"},{"key":"421_CR10","doi-asserted-by":"crossref","unstructured":"Millar MM, Grammer LC. Case reports of evaluation and desensitization for anti-thymocyte globulin hypersensitivity. Ann Allergy Asthma Immunol. 2000;85(4):311-6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11061475\/10.1016\/S1081-1206(10)62535-5","DOI":"10.1016\/S1081-1206(10)62535-5"},{"key":"421_CR11","doi-asserted-by":"crossref","unstructured":"Bielory L, Wright R, Nienhuis AW, Young NS, Kaliner MA. Antithymocyte globulin hypersensitivity in bone marrow failure patients. JAMA. 1988;260(21):3164-7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/3263515\/","DOI":"10.1001\/jama.1988.03410210076040"},{"key":"421_CR12","doi-asserted-by":"crossref","unstructured":"Ventura MT, Boni E, Taborda-Barata L, Blain H, Bousquet J. Anaphylaxis in elderly people. Curr Opin Allergy Clin Immunol. 2022;22(6):435\u2013\u200940. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36165408\/10.1097\/ACI.0000000000000855","DOI":"10.1097\/ACI.0000000000000855"},{"key":"421_CR13","unstructured":"Alvarez-Cuesta E, Madrigal-Burgaleta R, Broyles AD, Cuesta-Herranz J, Guzman-Melendez MA, Maciag MC et al. Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement. World Allergy Organ J. 2022;15(6):100640. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35694005\/"},{"key":"421_CR14","unstructured":"Tsai M, Pham A, Rapid intravenous desensitization to horse antithymocyte globulin in, a woman with severe aplastic anemia. Ann Allergy Asthma Immunol. 2018;121:S63\u2013\u2009S134. Available from: https:\/\/www.annallergy.org\/article\/S1081-1206(1810.1016\/j.anai.2018.09.241)"},{"key":"421_CR15","doi-asserted-by":"crossref","unstructured":"Demir E, Cigerci G\u00fcnayd\u0131n N, Karada\u015f N, G\u00fclen F, Tanac R, Y\u0131lmaz D. A successful desensitization protocol for horse-derived antithymocyte globulin in severe aplastic anemia. Pediatr Allergy Immunol. 2015;26(2):168\u2013\u200972. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25605658\/10.1111\/pai.12335","DOI":"10.1111\/pai.12335"},{"key":"421_CR16","doi-asserted-by":"crossref","unstructured":"Hall M, Hagemann TM. Successful desensitization to antithymocyte globulin in a child with aplastic anemia. Am J Health Syst Pharm. 2006;63(17):1633-6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16914633\/10.2146\/ajhp050422","DOI":"10.2146\/ajhp050422"},{"key":"421_CR17","doi-asserted-by":"crossref","unstructured":"Ferdman RM, Wakim M, Church JA, Hofstra TC, Thomas D, Genyk YS. Rapid intravenous desensitization to antithymocyte globulin in a patient with aplastic anemia. Transplantation. 2004;77(2):321-3. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/14743005\/10.1097\/01.TP.0000093465.31906.CA","DOI":"10.1097\/01.TP.0000093465.31906.CA"},{"key":"421_CR18","doi-asserted-by":"crossref","unstructured":"Ansotegui IJ, Melioli G, Canonica GW, Caraballo L, Villa E, Ebisawa M et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 2020;13(2):100080. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32128023\/10.1016\/j.waojou.2019.100080","DOI":"10.1016\/j.waojou.2019.100080"},{"key":"421_CR19","doi-asserted-by":"crossref","unstructured":"Sangiolo D, Storb R, Deeg HJ, Flowers ME, Martin PJ, Sandmaier BM et al. Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age. Biol Blood Marrow Transplant. 2010;16(10):1411-8. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20403449\/10.1016\/j.bbmt.2010.04.005","DOI":"10.1016\/j.bbmt.2010.04.005"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00421-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-025-00421-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-025-00421-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T12:09:02Z","timestamp":1740571742000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-025-00421-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["421"],"URL":"https:\/\/doi.org\/10.1186\/s40780-025-00421-w","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the Kameda Medical Center (Numbers: 24\u2009\u2212\u2009006). Informed consent for this report was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}